NFE2L2 and non-small cell lung carcinoma: The stabilization of cysteine dioxygenase 1 (CDO1) and enhanced entrance of cysteine into the taurine production pathway led to cysteine buildup mediated by NRF2, which was a metabolic vulnerability in non-small cell lung cancer (NSCLC) cells (Kang et al. 2019).